Determinants of drug response in camptothecin-11-resistant glioma cell lines Yoshihito MatsumotoTakashi FujiwaraSeigo Nagao OriginalPaper Pages: 1 - 8
Growth-inhibiting effect of intratumoral recombinant human tumor necrosis factor on an experimental model of primitive neuroectodermal tumor Jesús VaqueroMercedes ZuritaSantiago Oya OriginalPaper Pages: 9 - 14
An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells Stephen M. SagarKristen J. Price OriginalPaper Pages: 15 - 21
Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470 Takahito YazakiYoshiaki TakamiyaRobert L. Martuza OriginalPaper Pages: 23 - 29
Analysis of CerbB2 protein content of human glioma cells and tumor tissue Herbert H. EngelhardMark WoltersPeggy S. Criswell OriginalPaper Pages: 31 - 40
Increased intracellular cyclic AMP levels suppress the mitogenic responses of human astrocytoma cells to growth factors Chon-Haw TsaiLi-Man HungJan-Kan Chen OriginalPaper Pages: 41 - 52
Clinical application of18F-FUdR in glioma patients — PET study of nucleic acid metabolism Motonobu KameyamaKiichi IshiwataTatsuo Ido OriginalPaper Pages: 53 - 61
Turcot's syndrome: Case report and review of the classification Luigi CervoniPaolo CelliAldo Fortuna OriginalPaper Pages: 63 - 66
Positron emission tomographic assessment of cerebral hemocirculation and glucose metabolism in malignant glioma following treatment with intracarotid recombinant human tumor necrosis factor-α Toshio SasajimaKatsuyoshi MineuraKazuo Uemura OriginalPaper Pages: 67 - 73
Single brain metastases from unknown primary malignancies in CT-era Maurizio SalvatiLuigi CervoniAntonino Raco OriginalPaper Pages: 75 - 80
Intraoperative radiotherapy for gliomas Takashi FujiwaraYutaka HonmaMasatada Tanabe OriginalPaper Pages: 81 - 86
Phase II study of amonafide in patients with recurrent glioma Ralph LevittJan C. BucknerBernd W. Scheithauer OriginalPaper Pages: 87 - 93